REFINVERSE Group, Inc. AI Stock Analysis
Want to see JP:7375 full AI Analyst Report?
REFINVERSE Group, Inc. (7375) AI Stock Analysis
REFINVERSE Group, Inc.
(TSE/TYO:7375)
REFINVERSE scores modestly as an improving but still fragile business. The dominant factor is financial performance: profitability has recovered strongly, with record revenue, expanding margins and net profit of ¥256m, yet the balance sheet remains stretched at roughly 4.3x debt-to-equity with equity covering only 15% of assets, and free cash flow has fallen sharply on heavy capital spending. Technicals add further pressure, with the shares trading well below all key moving averages and a firmly negative MACD signalling a sustained downtrend. Valuation provides some offset — a P/E near 11.7 is inexpensive — but the absence of a dividend and the company's leverage justify much of that discount. No earnings call or corporate event data was available, so those components were excluded and their weight redistributed.
REFINVERSE Group, Inc. (7375) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 2.49B
- Dividend Yield
- ―
- Average Volume (3M)
- 52.68K
- Price to Earnings (P/E)
- 18.8
- Beta (1Y)
- 0.77
- Revenue Growth
- 15.57%
- EPS Growth
- 15.07%
- Country
- Japan
- Employees
- 227
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals
REFINVERSE Group, Inc. Business Overview & Revenue Model
Company Description
Based in Japan, REFINVERSE Group, Inc. operates as a specialist in material recovery and recycling. The company conducts its business through two distinct divisions: the Materials Business and the Resource Business. Within its Materials segment, the...
REFINVERSE Group, Inc. Financial Statement Overview
Summary
A turnaround in progress with clear strengths and one major weakness. The income statement (63) is the bright spot: revenue of ¥4.46bn is at a record high, up ~10% year over year, gross margin has expanded to 36.4%, operating margin to 7.2%, and net profit recovered to ¥256m from a near-breakeven prior year and a ¥505m loss in FY2023. Cash flow (52) is genuinely positive with operating cash flow of ¥323m covering net income 1.3x, but free cash flow collapsed to ¥97m as capital spending absorbed ~70% of operating cash. The balance sheet (33) is the clear vulnerability: ¥2.28bn of debt against just ¥535m of equity (4.3x) and an equity base equal to only 15% of assets leaves minimal margin for error, despite meaningful deleveraging from FY2023 levels. Operating momentum is encouraging, but financial fragility caps the score.
Income Statement
63PositiveBalance Sheet
33NegativeCash Flow
52Neutral| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.46B | 4.46B | 4.07B | 3.85B | 3.73B | 4.47B |
| Gross Profit | 1.63B | 1.63B | 1.32B | 1.21B | 1.10B | 1.35B |
| EBITDA | 527.73M | 527.73M | 408.06M | 257.07M | 480.30M | 538.97M |
| Net Income | 255.52M | 255.52M | 146.08M | 4.93M | 182.85M | -504.84M |
Balance Sheet | ||||||
| Total Assets | 3.63B | 3.63B | 3.49B | 3.37B | 3.25B | 3.78B |
| Cash, Cash Equivalents and Short-Term Investments | 274.69M | 274.69M | 692.22M | 511.96M | 934.96M | 872.96M |
| Total Debt | 2.28B | 2.28B | 2.58B | 2.67B | 2.06B | 3.00B |
| Total Liabilities | 3.10B | 3.10B | 3.22B | 3.24B | 2.68B | 3.68B |
| Stockholders Equity | 534.59M | 534.59M | 274.41M | 130.21M | 570.06M | 99.70M |
Cash Flow | ||||||
| Free Cash Flow | 0 | 97.33M | 299.52M | 90.15M | 374.03M | 405.01M |
| Operating Cash Flow | 0 | 322.60M | 459.66M | 175.41M | 476.46M | 530.96M |
| Investing Cash Flow | 0 | -283.68M | -126.06M | -136.56M | -92.77M | -317.70M |
| Financing Cash Flow | 0 | -456.46M | -153.33M | -399.86M | 40.34M | -266.26M |
REFINVERSE Group, Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7375, the sentiment is Negative. The current price of 753.00 is below the 20-day moving average (MA) of 997.60, below the 50-day MA of 1144.26, and below the 200-day MA of 1266.59, indicating a bearish trend. The MACD of -86.69 indicates Positive momentum. The RSI at 25.86 is Positive, neither overbought nor oversold. The STOCH value of 7.29 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7375.
REFINVERSE Group, Inc. Peers Comparison
Overall Rating
JP:412475Outperform
JP:404067Neutral
JP:410261Neutral
JP:488552Neutral
JP:737551Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 75Outperform | JPY 2.37B | 13.84 | ― | 2.21% | 16.49% | ― | |
| 67Neutral | JPY 8.63B | 2.24 | ― | 1.75% | -0.40% | 215.27% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 61Neutral | JPY 3.21B | 8.49 | ― | 4.18% | 8.59% | 119.18% | |
| 52Neutral | JPY 3.02B | 13.06 | ― | 3.05% | 14.73% | 7.50% | |
| 51Neutral | JPY 2.68B | 18.77 | ― | ― | 15.57% | 15.07% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7375 | REFINVERSE Group, Inc. | 753.00 | -42.00 | -5.28% | |
| JP:4040 | NANKAI CHEMICAL COMPANY LIMITED | 3470.00 | 545.16 | 18.64% | |
| JP:4102 | Maruo Calcium Co., Ltd. | 1435.00 | 62.54 | 4.56% | |
| JP:4124 | Osaka Yuka Industry Ltd. | 2842.00 | 383.40 | 15.59% | |
| JP:4885 | MUROMACHI CHEMICALS INC. | 784.00 | 66.46 | 9.26% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 16, 2026
